Search filters

List of works by Keith Stockerl-Goldstein

A Multi-Modal Diagnostic Model Improves Detection of Cardiac Amyloidosis Among Patients with Diagnostic Confirmation by Cardiac Biopsy

scientific article published on 16 November 2020

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

scientific article published on 02 May 2019

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

scientific article published on 05 April 2019

A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

scientific article published on 28 August 2015

A decade of progress in allogeneic hematopoietic cell transplantation: 1990-2000.

scientific article

A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer

scientific article published on November 1999

A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.

scientific article published in August 2009

A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML

scientific article published on 25 July 2012

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

scientific article

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

scientific article published on 10 March 2017

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

scientific article

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

scientific article

A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.

scientific article

A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

scientific article published on 05 October 2015

A phase I study of thymoglobulin for relapsed or refractory multiple myeloma

scientific article published on 19 June 2015

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.

scientific article published in September 2009

A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma

scientific article published on 28 July 2014

A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects

scientific article published in April 2004

A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome.

scientific article published on 27 April 2016

Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.

scientific article

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

scientific article published on 24 January 2017

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

scientific article

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.

scientific article published on 2 September 2015

Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study

scientific article published on 24 November 2008

CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies

scientific article published on 01 March 2005

Cardio-Oncology Education and Training: JACC Council Perspectives

scientific article published on 01 November 2020

Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement

scientific article published on 10 September 2020

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

scientific article published on 27 June 2014

Carfilzomib: a second-generation proteasome inhibitor for the treatment of multiple myeloma

scientific article

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study

scientific article published on 31 July 2011

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

scientific article published on 28 May 2020

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.

scientific article published on 3 August 2011

Commentary

scientific article published on 01 April 2012

DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma

scientific article published on 04 March 2020

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

scientific article published on 24 March 2015

Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy

scientific article published on 13 August 2016

Effect of oral glutamine supplementation during bone marrow transplantation

scientific article published on March 2000

Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

scientific article published in January 2001

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study

scientific article published on 29 May 2018

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

scientific article published on 24 June 2019

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose

scientific article published on 30 November 2004

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial

scientific article published on 01 January 2000

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

scientific article published in January 2000

Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy

scientific article published on January 2000

Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies

scientific article published on 01 December 1997

Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation

scientific article published on 17 March 2017

GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma

scientific article published on 09 September 2019

Geriatric Assessment in Older Adults with Multiple Myeloma

scientific article published on 13 December 2018

Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients

scientific article published on 31 March 2015

Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

scientific article published on 20 April 2020

High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma

scientific article published in July 2006

High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California

scientific article published in January 2000

High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience

scientific article

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience

scientific article published in January 2001

High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma

scientific article published on 11 May 2015

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma

scientific article published on January 2000

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.

scientific article published on 13 February 2018

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma

scientific article published in January 2000

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study

scientific article published on 01 April 1999

Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation

scientific article published on 7 December 2017

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation

scientific article published on January 1999

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

scientific article published in September 2008

Influence of body mass index on survival in veterans with multiple myeloma

scientific article published on 18 September 2013

Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma

scientific article published on 01 May 1996

Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells

scientific article

Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.

scientific article published on 10 November 2017

Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

scientific article

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma

scientific article published on 28 August 2019

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

scientific article published on 14 March 2017

Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia

scientific article published on 21 August 2020

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

scientific article published on 21 June 2018

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology

scientific article published on November 2015

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published on February 2017

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 02 December 2020

Multiple myeloma

scientific article published on 01 October 2011

Multiple myeloma, version 1.2013.

scientific article published in January 2013

Multiple myeloma. Clinical practice guidelines in oncology

scientific article published on 01 February 2007

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

scientific article published on 01 October 2019

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

scientific article

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

scientific article published in January 2018

NCCN clinical practice guidelines in oncology: multiple myeloma

scientific article published on 01 October 2009

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study

scientific article published on 19 January 2019

Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature.

scientific article published on 28 October 2011

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

scientific article published on 01 June 2019

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

scientific article published on 23 October 2017

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.

scientific article published on 22 July 2016

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.

scientific article published on 2 February 2014

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia

scientific article

Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection

scientific article published on 2 May 2017

Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

scientific article published on 26 August 2016

Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

scientific article published on 06 October 2019

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation

scientific article

Protective conditioning for acute graft-versus-host disease

scientific article published on 01 September 2005

Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation

scientific article

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

scientific article

Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies

scientific article published in June 2001

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

scientific article published on 01 February 2002

Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma

scientific article published on August 1, 1997

Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.

scientific article published on 11 March 2015

Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation

scientific article published on 17 June 2016

Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymp

scientific article published on 7 August 2017

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma

scientific article published on 05 November 2018

Retrospective comparison of allogeneic vs autologous transplantation for diffuse large B-cell lymphoma with early relapse or primary induction failure

scientific article published on 22 September 2014

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

scientific article

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

scientific article published on 7 August 2003

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.

scientific article published in November 2009

Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data

scientific article published on 31 July 2018

Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

scientific article published on 21 November 2019

Socioeconomic status is independently associated with overall survival in patients with multiple myeloma

scientific article published on 4 February 2015

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

scientific article

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma

scientific article published on 23 May 2011

The Effect of Donor Type on Outcomes in Adults with Acute Myeloid Leukemia after Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant

scientific article published on 29 May 2020

The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide.

scientific article published on 24 June 2013

The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation

scientific article published on 31 May 2016

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma

scientific article published in January 2000

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer

scientific article published on January 2000

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

scientific article

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

scientific article published in October 2012

Paulina is supported by:

About Paulina

Help